ArticleMolecular therapy. Oncology2026

StagX1, an isoquinolinone compound, selectively targets CES1-positive Ewing sarcoma cells as a potential therapeutic agent.

Nenggang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.